Excellence can be found at every level and every location of Regional Cancer Care Associates, and others are taking notice.
The Washington Post in conjunction with the American Nurses Association recently named Heid Barber McDonald, RN, BSN, OCN, community hematology-oncology, as a Washington Post Star Nurse finalist.
McDonald is a clinical chemotherapy infusion nurse for the Regional Cancer Care Associates Maryland Division. She is one of more than 60 nurses out of hundreds to be named a Star Nurse finalist. Finalists are nominated by patients, family members, peers and members of the community for demonstrating nursing excellence.
Each year, The Washington Post and American Nurses Association recognize and celebrate nurses working in Maryland, Virginia and the District of Columbia. The finalists are selected from a pool of women and men who work on the front lines of health and represent the epitome of skill, professionalism and care.
From the 2021 Star Nurses, six will receive the Nightingale Award. The award will be presented May 26 to two nurses from each state and the District of Columbia.
With more than 125 cancer specialists practicing at 20+ care centers located throughout New Jersey, Connecticut, Maryland, and the Washington, D.C. area, RCCA provides care to roughly 24,500 new cancer patients and 245,000 established patients each year. RCCA offers those patients immunotherapy, targeted treatment, cell-based therapy and other cutting-edge treatments and diagnostic modalities, as well as access to clinical trials.
For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Black Americans with lung cancer are 18% less likely than white people to be diagnosed in the early stages of the disease, 23% less likely to receive surgery, and 21% less likely to survive 5 years after diagnosis, according to the American Lung Association.
Cancer can affect anyone from any background. However, some racial and ethnic groups have higher rates of certain kinds of cancer. Regional Cancer Care Associates
Infusion therapy is a treatment modality that administers medications intravenously. While most people associate infusions with cancer treatment, several different conditions can be managed and
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.
